We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BOVNF market cap is 309.28M. The company's latest EPS is SEK -0.6459 and P/E is -7.28.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 38.55M | 93.74M | 147.37M | 19.38M | 326.13M |
| Operating Income | -123.08M | -137M | -74.96M | -278.17M | -50.47M |
| Net Income | -123.16M | -138.63M | -76.33M | -278.44M | -42.5M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 120.4M | 226.11M | 802.64M | 1.45B | 1.71B |
| Total Liabilities | 32.78M | 56.68M | 59.14M | 80.32M | 106.09M |
| Total Equity | 87.62M | 169.44M | 743.5M | 1.37B | 1.61B |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | -141.39M | -125.43M | -62.62M | -245.84M | -41.23M |
| Investing | -3.85M | -3.84M | -6.7M | -467.54M | -628.85M |
| Financing | 80.33M | 214.39M | 644.62M | 894.87M | 273.49M |
| Market Cap | 309.28M |
| Price to Earnings Ratio | -7.28 |
| Price to Sales Ratio | 0.95 |
| Price to Cash Ratio | 0.6 |
| Price to Book Ratio | 0.19 |
| Dividend Yield | - |
| Shares Outstanding | 65.8M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 1 (31.15%) |
| Company Name | Bioinvent International AB (PK) |
| Address |
the gamma building lund SE-223 70 |
| Website | https://www.bioinvent.com |
| Industry | drugs-health r&d/testing labs (H8) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
